The article ''Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a14C-microtracer and therapeutic dose in cancer patients'', written by L. van Andel, H. Rosing, Z. Zhang, L. Hughes, V. Kansra, M. Sanghvi, M. M. Tibben, A. Gebretensae, J. H. M. Schellens and J. H. Beijnen, was originally published electronically on the publisher's internet portal (currently SpringerLink) on 17th October 2017 without open access
Correction to: Cancer Chemother Pharmacol (2017) 80:1171–1178 https://doi-org.proxy.library.uu.nl/10...
Only after the article was published online did the authors notice the misspelling of the second aut...
An amendment to this paper has been published and can be accessed via the original article.</jats:p
An amendment to this paper has been published and can be accessed via the original article
Following publication of the original article [1], the author reported two errors in the authors aff...
The original version of this Article omitted the following from the Acknowledgements: ‘This work was...
The article Reversal agents for oral anticoagulant-associated major or life-threatening bleeding, wr...
The original version of this article unfortunately contained a mistake. Due to a typesetting error ‘...
The article “Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer” writt...
\u3cp\u3eThe original version of this Article omitted the following from the Acknowledgements: ‘This...
An Online First version of this article was made available online at http://link.springer.com/journa...
An amendment to this paper has been published and can be accessed via a link at the top of the paper...
The original version of this article was published open access. Unfortunately, due to a technical is...
The therapeutic experience reported in the paper was conceived after the use of nimotuzumab and radi...
The original version of the published Article contained an incorrect citation for reference 20 “Hubb...
Correction to: Cancer Chemother Pharmacol (2017) 80:1171–1178 https://doi-org.proxy.library.uu.nl/10...
Only after the article was published online did the authors notice the misspelling of the second aut...
An amendment to this paper has been published and can be accessed via the original article.</jats:p
An amendment to this paper has been published and can be accessed via the original article
Following publication of the original article [1], the author reported two errors in the authors aff...
The original version of this Article omitted the following from the Acknowledgements: ‘This work was...
The article Reversal agents for oral anticoagulant-associated major or life-threatening bleeding, wr...
The original version of this article unfortunately contained a mistake. Due to a typesetting error ‘...
The article “Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer” writt...
\u3cp\u3eThe original version of this Article omitted the following from the Acknowledgements: ‘This...
An Online First version of this article was made available online at http://link.springer.com/journa...
An amendment to this paper has been published and can be accessed via a link at the top of the paper...
The original version of this article was published open access. Unfortunately, due to a technical is...
The therapeutic experience reported in the paper was conceived after the use of nimotuzumab and radi...
The original version of the published Article contained an incorrect citation for reference 20 “Hubb...
Correction to: Cancer Chemother Pharmacol (2017) 80:1171–1178 https://doi-org.proxy.library.uu.nl/10...
Only after the article was published online did the authors notice the misspelling of the second aut...
An amendment to this paper has been published and can be accessed via the original article.</jats:p